Pharmaceutical & Life Sciences News

CEO Named in Opioid Lawsuits to Reap $68 Million for Year’s Work

Dec. 3, 2019, 6:22 PM

Mark Timney faces the kind of allegations that can end careers.

The former Purdue Pharma LP chief executive officer is accused of playing a key role in fueling the opioid crisis, according to scores of lawsuits by state attorneys general and others. They allege that he directed staff to mislead doctors about the addictiveness of painkillers, which devastated communities across the U.S.

But outside the courtroom, Timney has already begun -- and almost finished -- his next act, which will pay him handsomely for just a year’s work.

Last December, about 18 months after leaving Purdue, Timney became CEO of...

To read the full article log in. To learn more about a subscription click here.